Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG35312

H4C1 Knockout AGS Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Stomach

  • Disease:

    Adenocarcinoma

The H4C1 Knockout AGS Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population targeting the H4C1 gene in AGS human gastric adenocarcinoma cells. H4C1 encodes a replication-dependent histone H4 variant that is critical for nucleosome assembly and chromatin organization, with expression regulated by Cyclin E/CDK2 and E2F transcription factors. This polyclonal model enables loss-of-function studies of histone H4 in a gastric cancer background, supporting applications in chromatin dynamics, epigenetic regulation, cell cycle progression, DNA damage response, and drug sensitivity testing. Representative assays include ChIP-seq, RNA-seq, flow cytometry, and viability screens.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    AGS

    Sex of Donor

    Female

    Age

    54 years

    Derived From Site

    In situ; Stomach

    Gene Name

    H4C1

    Gene Identifier

    NCBI Gene ID 8359

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    Ham's F-12

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The H4C1 Knockout AGS Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the AGS human gastric adenocarcinoma cell line. This product features targeted disruption of the H4C1 gene, which encodes a core replication-dependent histone H4 variant. As a polyclonal population, the cells carry a heterogeneous spectrum of CRISPR-induced edits within H4C1, providing a versatile loss-of-function model for studying histone H4 biology without monoclonal selection artifacts. This knockout model enables investigation of H4C1-dependent processes in a gastric epithelial context.

The parental AGS cell line originates from a human gastric adenocarcinoma and displays adherent epithelial morphology. Widely utilized as a model for gastric cancer, these cells recapitulate aspects of epithelial barrier function and uncontrolled proliferation characteristic of gastric malignancies. The AGS background provides a clinically relevant platform for exploring oncogenic mechanisms and therapeutic vulnerabilities in the stomach. Combined with H4C1 knockout, this system is particularly suited for dissecting epigenetic contributions to gastric adenocarcinoma progression.

H4C1 encodes histone H4, a core nucleosome component essential for chromatin organization. Its expression is replication-dependent, controlled in S phase by E2F transcription factors and the NPAT/HiNF-P complex downstream of Cyclin E/CDK2, with SLBP coordinating mRNA processing. H4 protein forms octamers with H2A, H2B, and H3 and is deposited onto DNA by chaperones including CAF-1, ASF1, and NAP1. This orchestrated assembly is vital for nucleosome formation, genomic stability, and epigenetic regulation. Knockout of H4C1 disrupts nucleosome occupancy, leading to aberrant chromatin accessibility, transcriptional dysregulation, and replication stress.

In the AGS gastric adenocarcinoma model, H4C1 loss-of-function provides a means to interrogate how replication-coupled histone supply impacts cancer cell behavior. By impairing proper chromatin assembly, the knockout can reveal synthetic lethal interactions, epigenetic vulnerabilities, and altered DNA damage responses unique to gastric epithelial cells. This model enables researchers to connect histone dynamics with oncogenic signaling pathways and identify potential therapeutic targets in gastric cancer. Because H4C1 is a core histone, its disruption broadly affects cell cycle progression and genome integrity, making it a powerful tool for studying epigenetic dysregulation in a disease-relevant context.

Typical applications include functional genomics using RNA-seq and ChIP-seq, cell cycle flow cytometry, proliferation assays, colony formation, migration/invasion studies, and drug sensitivity profiling. These cells enable population-level analysis of H4C1 loss without clonal artifacts, facilitating reproducible studies of histone biology. For more information or custom inquiries, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)